View the official press release distributed through PR Newswire.
nRichDX®, maker of the Revolution Sample Prep System™ for liquid biopsy applications, exhibited at booth #822 during the AMP 2023 Annual Meeting & Expo in Salt Lake City, Utah.
IRVINE, Calif., October 12, 2023 – The Association for Molecular Pathology 2023 Annual Meeting & Expo will be held November 14-18, 2023 at the Salt Palace Convention Center in Salt Lake City, Utah.
nRichDX will exhibit in booth #822. Exhibits open at 11:15 AM MT on Thursday, November 16 and close at 1:30 PM on Saturday, November 18.
nRichDX at the AMP Annual Meeting & Expo
Scientific research, platform performance data, and liquid biopsy sample preparation solutions.
nRichDX exhibit booth #822
Collaborative scientific poster with Agilent Technologies
Innovation Spotlight Stage presentation featuring Revolution System performance data
Revolution Sample Prep System and Revolution CTC Enrichment Kit information
Collaborative Poster with Agilent Technologies
nRichDX will present a poster in collaboration with Agilent Technologies titled:
Unraveling the Link Between Total cfDNA Quantified by Agilent TapeStation cfDNA ScreenTape and Actionable cfDNA Molecules Measured on Downstream Assays
Revolution Sample Prep System Performance Data
nRichDX will also deliver a presentation titled The nRichDX Revolution Sample Prep System for Liquid Biopsy – Overview and Performance Data from Innovation Spotlight Stage 2 in the Expo Hall on Thursday, November 16 at 12:40 PM local time.
The presentation will include customer data and experience directly from Revolution System users, including Dr. Shiva Sathyanarayana from the laboratory of Dr. Greg Tsongalis, Professor and Vice Chair for Research, Medical Director, Clinical Genomics and Advanced Technology (CGAT) at Dartmouth-Hitchcock Medical Center.
Liquid Biopsy Sample Preparation Solutions
The nRichDX booth will feature the latest information on the Revolution Sample Prep System and associated products for pre-analytical sample handling and isolation of liquid biopsy analytes from plasma and urine.
Applications highlighted at the meeting include cfDNA, cfRNA, and cell-free total nucleic acid (cfTNA) extraction.
Information will also be available about the Revolution CTC Enrichment Kit (Epithelial Origin) for enrichment of circulating tumor cells originating from epithelial tissues in whole blood.
Explore the Revolution PlatformSupporting Higher Analyte Yield
AMP attendees working on or considering liquid biopsy assays, the extraction of cfDNA, cfRNA, circulating cell-free total nucleic acid (cfTNA), or the enrichment of CTCs were especially invited to visit the nRichDX booth.
The company highlighted how higher yields of these analytes can increase assay performance through improved sensitivity and earlier detection of targeted oncology markers.
About nRichDX
nRichDX® is an emerging leader in sample prep solutions for the isolation of cfDNA and cfRNA and the enrichment of CTCs. The patented Revolution Sample Prep System™ is engineered specifically for liquid biopsy applications.
It is the first and only high-yield, high-recovery, IVD-labeled sample prep platform that can process from 1 mL to 20 mL of plasma or urine sample volumes or up to 40 mL of blood in a single extraction using the company's patented nRicher Cartridge™.
Unlike other methods, Revolution sample prep doesn't require yield-lowering eluate pooling or sample transfer steps. nRichDX helps solve one of precision medicine's greatest problems: inaccurate or incomplete diagnostic results for liquid biopsy-based applications due to insufficient analyte.
Learn more about nRichDX